论文部分内容阅读
目的探讨不稳定型心绞痛的临床治疗措施。方法回顾分析70例患者的临床资料。结果本组患者经4周治疗后,对照组35例中,显效9例,有效19例,无效7例;治疗组35例中,显效10例,有效24例,无效1例;与对照组比较,有统计学差异P<0.05。结论曲美他嗪可有效地控制不稳定型心绞痛的症状,减少缺血发作次数、缺血持续时间,有效治疗不稳定型心绞痛。总之,曲美它嗪联合常规治疗能有效的缓解心绞痛症状,特别是对无介入条件的基层医院,值得临床推广。
Objective To investigate the clinical treatment of unstable angina pectoris. Methods The clinical data of 70 patients were retrospectively analyzed. Results After 4 weeks of treatment, the control group of 35 cases, markedly effective in 9 cases, effective in 19 cases, invalid in 7 cases; treatment group 35 cases, markedly effective in 10 cases, effective in 24 cases, 1 case of ineffective; compared with the control group , There is statistical difference P <0.05. Conclusion Trimetazidine can effectively control the symptoms of unstable angina, reduce the number of ischemic attacks and the duration of ischemia, and effectively treat unstable angina pectoris. In short, trimetazidine combined with conventional treatment can effectively alleviate the symptoms of angina pectoris, especially for grass-roots hospitals without interventional conditions, worthy of clinical promotion.